Loading chart…
PRE-MARKET
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, and sells pharmaceutical formulations in India and internationally. The company provides tablets, capsules, dry syrups, oral liquids, ointments, and other pharmaceutical dosage forms. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins and supplements, antibiotics, pain management, and other generics.
Medicamen Biotech Limited (MEDICAMEQ) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The MEDICAMEQ share price is ₹279.55 (+1.40% today), with a market capitalisation of ₹4B and a price-to-earnings (P/E) ratio of 37.7. MarketRipple tracks the MEDICAMEQ investment thesis, the ripple-chain impact of market events on Medicamen Biotech Limited, and the Healthcare sector outlook.
Open
₹283.75
High
₹286.95
Low
₹275.65
Prev. Close
₹275.70
52W High
₹447.65
52W Low
₹212.40
Day range
₹275.65–₹286.95
52-week range
₹212.40–₹447.65
Volume
3K
P/E
37.7
ROE
3.5%
D/E
0.18
Margin
4.7%
Medicamen Biotech Limited (NSE: MEDICAMEQ) is currently trading at ₹279.55 (+1.40%).
Medicamen Biotech Limited's market capitalization is ₹4B.
Medicamen Biotech Limited's price-to-earnings (P/E) ratio is 37.7.
Medicamen Biotech Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).